An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis

Accumulating evidence shows that a propensity towards a pro-inflammatory status in the brain plays an important role in schizophrenia. Anti-inflammatory drugs might compensate this propensity. This study provides an update regarding the efficacy of agents with some anti-inflammatory actions for schizophrenia symptoms tested in randomized controlled trials (RCTs).PubMed, Embase, the National Institutes of Health website...